Clinical Trial Update: Dose Finding Study Depigoid Phleum: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma [Phase 2]

View source ↗

Summary

Phase 2 dose-finding study evaluating four doses of Depigoid Phleum in patients with allergic rhinitis/rhinoconjunctivitis, with or without intermittent asthma,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Intermittent Asthma
• Rhinoconjunctivitis

Drugs mentioned

• Depigoid Phleum

Snippet

Sponsor: Leti Pharma GmbH | Conditions: Allergic Rhinitis/Rhinoconjunctivitis +- Intermittent Asthma, Sensitization Against Phleum Pratense Pollen | Phase 2 | Status: COMPLETED